Organ and tumor dosimetry of [(161)Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC.
- DOI
- 10.1007/s00259-026-08171-z
- Published
- 2026 Sep 8
- Container
- European journal of nuclear medicine and molecular imaging
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00259-026-08171-z,
title = {Organ and tumor dosimetry of [(161)Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC.},
author = {Schaefer-Schuler A and Blickle A and Ganz S and Petto S and Burgard C and Speicher T and Bastian MB and Maus S and Bartholomä M and Ezziddin S and Rosar F},
year = {2026},
journal = {European journal of nuclear medicine and molecular imaging},
doi = {10.1007/s00259-026-08171-z},
url = {https://doi.org/10.1007/s00259-026-08171-z}
}RIS
TY - JOUR TI - Organ and tumor dosimetry of [(161)Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC. AU - Schaefer-Schuler A AU - Blickle A AU - Ganz S AU - Petto S AU - Burgard C AU - Speicher T AU - Bastian MB AU - Maus S AU - Bartholomä M AU - Ezziddin S AU - Rosar F PY - 2026 JO - European journal of nuclear medicine and molecular imaging DO - 10.1007/s00259-026-08171-z UR - https://doi.org/10.1007/s00259-026-08171-z ER -
APA
A, S., A, B., S, G., S, P., C, B., T, S., MB, B., S, M., M, B., S, E., & F, R. (2026). Organ and tumor dosimetry of [(161)Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC.. European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-026-08171-z
Source records
- pubmed · retrieved 2026-09-25T14:24:55.411Z